• The extraordinary demand for COVID-19 testing kits that were seen in 2020 and is yet to subside in 2021 resulted in many of the world?s biggest diagnostics companies being thrust into the limelight
• Siemens Healthineers- GE Healthcare- Roche- and Abbott are the top players in the race of the global diagnostic companies. The companies are in the race to develop fast- accurate methods for detecting patients infected with the SARS-CoV-2 virus  
• Our team at PharmaShots has compiled a list of the top 20 diagnostics companies based on their 2020 diagnostics revenue

Diagnostic Revenue: $0.58B                                                         Total Employees: ~2-000

Founded Year: 2017                                                                       Stock Exchange: NASDAQ

Market Cap: ?~$1.05B????????????????????????????????????????????????????????????????????Headquarters: Utah- US

Varex Imaging is a leading innovator- designer and manufacturer of X-ray tubes- digital detectors- linear accelerators- and other image software processing solutions. The company is one the largest global manufacturers of X-ray components and each year- it produces over 27-000 X-ray tubes and 20-000 X-ray detectors.

Diagnostic Revenue: $0.94B                                                      Total Employees: ~22-200

Founded Year: 1940???????????????????????????????????????????????????????????????????? Stock Exchange: BME

Market Cap:  ~$16.03B                                                                Headquarters: California- United States

Grifols is a global healthcare company dedicated to improving the health and well-being of people around the globe and is divided into four divisions- Bioscience- Diagnostic- Hospital- and Bio Supplies. In 2020- the EC approved Tavlesse (fostamatinib) to treat immune thrombocytopenia (ITP) in adult patients who are refractory to other treatment whereas- in Aug?2020- the FDA granted EUA for convalescent plasma to treat patients with COVID-19. In Sept?2021- the company acquired the remaining stake in Alkahest to boost its R&D efforts.

Diagnostic Revenue: $0.97B                                                         Total Employees: ~44-961

Founded Year: 1873                                                                         Stock Exchange: TYO

Market Cap:~$2.94B                                                                       Headquarters: Tokyo- Japan

Konica Minolta is the global developer- manufacturer of multi-functional peripherals (MFPs)- equipment for production print systems and graphic arts- equipment for healthcare systems- measuring instruments for healthcare applications- and related consumables and solution services. The company is dealing with ultrasounds- digital radiography and has a healthcare T segment as well. SONIMAGE MX1 is a POC ultrasound system that delivers advanced technology to ensure excellent image quality and efficient workflow with exceptional value.

Diagnostic Revenue: $1.07B                                                          Total Employees: ~2-045

Founded Year: 1968                                                                         Stock Exchange: BIT 

Market Cap: ??~$9.76B???????????????????????????????????????????????????????????????????? Headquarters: Saluggia- Italy

DiaSorin is an Italian in-vitro diagnostics firm and is involved in developing- producing- and commercializing diagnostic tests for a wide range of clinical areas. In Oct?2020- DiaSorin launches its new LIAISON SARS-CoV-2 Ag for quantitative detection of SARS-CoV-2 in symptomatic patients through nasal and nasopharyngeal swabs. In Apr?2021- DiaSorin to acquire Luminex for $1.8B to broaden its positioning in the molecular diagnostics space.

Diagnostic Revenue: $1.30B                                                         Total Employees: ~8-000

Founded Year: 1952                                                                        Stock Exchange: NYSE

Market Cap: ?~$17.31B???????????????????????????????????????????????????????????????? Headquarters: California- US

Bio-Rad is a leading healthcare industry involved in blood typing products- offering a wide variety of platforms- reagents- data management- and connectivity solutions. Bio-Rad operates in two industry segments designated as Life Science and Clinical Diagnostics and generated 49% and 51%- respectively. Bio-Rad offers SARS-CoV-2 / COVID-19 assay and research solutions to address the COVID-19 pandemic.

Diagnostic Revenue: $1.49B                                                            Total Employees: ~5-000

Founded Year: 1995                                                                            Stock Exchange: NASDAQ 

Market Cap: ~$20.39B?????????????????????????????????????????????????????????????????????? Headquarters: Madison- Wisconsin

Exact Sciences Corporation is a molecular diagnostics company focused on the early detection and prevention of some of the deadliest forms of cancer. In Dec?2020- the company reported the data from the RxPONDER trial that demonstrated the benefit of CT in early-stage- node-positive breast cancer.

Diagnostic Revenue: $1.76B                                                       Total Employees: ~4- 500

Founded Year: 1939                                                                      Stock Exchange: NASDAQ

Market Cap: $4.90B???????????????????????? ?????????????????????????????????????????????Headquarters: New Jersey- US

Ortho Clinical Diagnostics develops in-vitro products and diagnostic equipment for blood testing. The company operates in two lines of business- Clinical Laboratories and Transfusion Medicine. In Jan?2021- Ortho?s Vitros SARS-CoV-2 antigen test received the US FDA?s EUA for accurate- mass-scale COVID-19 testing.

Diagnostic Revenue: $2.07B                                                          Total Employees: ~6-000

Founded Year: 1986????????????????????????????? ???????????????????????????????????????????Stock Exchange: NASDAQ

Market Cap: ??~$15.84B???????????????????????????????????????????????????????????????????Headquarters: Massachusetts- US?

Hologic is a medical technology company primarily focused on women?s health- beauty products development- and marketing medical devices for surgery and medical imaging. The diagnostic segments include our molecular diagnostic assays- which run on advanced instrumentation systems (Panther- Panther Fusion- and Tigris)- ThinPrep cytology system- and the Rapid Fetal Fibronectin Test. In 2020- in response to the COVID-19 global pandemic- it developed and launched Aptima SARS-CoV-2 assays for the detection of SARS-CoV-2.  The company also developed and launched the Panther Fusion SARS-CoV-2 assay for the detection of SARS-CoV-2- which has received the FDA?s EUA in Mar?2020.

Diagnostic Revenue: $2.73B????????????????????????????????????????????????????????Total Employees: ~9-000

Founded Year: 1968???????????????????????????????????????????????????????????????????????Stock Exchange: TYO

Market Cap: ~$21.53B                                                                   Headquarters: Kobe- Japan

Sysmex is a Japanese firm involved in the development- manufacturing- sales- and export/import of diagnostic instruments- reagents- and related software. To reduce the burden of Dementia- Sysmex collaborated with Eisai to develop a blood test that will enable diagnosis while placing less of a burden on the patient. The joint research aimed at enabling early-stage diagnoses- the selection of treatment methods and the monitoring of treatment results.

Diagnostic Revenue: $3.09B                                                          Total Employees: ~73-906

Founded Year: 1934                                                                         Stock Exchange: TYO

Market Cap: ~$36.03B????????????????????????????????????????????????????????????????????Headquarters: Tokyo- Japan

Fujifilm Medical is a leader in diagnostic imaging products and medical informatics solutions and is divided into three business categories: Imaging Solutions- Healthcare & Material Solutions- and Document Solutions. In 2020- The company commenced the development of an antigen test kit for diagnosis of SARS-CoV-2 infection and later- collaborated with Carelink in deploying Avigan in China. Additionally- Fujifilm concludes a manufacturing contract agreement with VLP Therapeutics- for a COVID-19 vaccine formulation.

Diagnostic Revenue: $4.22B                                                         Total Employees: ~ 181897

Founded Year: 1937??????????????????????????????????????????????????????????????????????? Stock Exchange: TYO

Market Cap: ??~$32.2?B???????????????????????????????????????????????????????????? Headquarters: Tokyo- Japan

Canon is a Japanese multinational corporation specialized in the manufacturing of imaging and optical products- including cameras- camcorders- photocopiers- steppers- computer printers- and medical equipment. In 2020- Canon developed and offered a suite of total solutions for diagnosing COVID-19 infections- for example- CT equipment- X-rays system- ultrasounds system- rapid COVID-19 genetic and antigen testing. In Japan- the company partnered with Nagasaki University to develop set of reagents for COVID-19 RNA testing.

Diagnostic Revenue: $4.70B                                                        Total Employees: ~70-093

Founded Year: 1895                                                                       Stock Exchange: NYSE

Market Cap: ~$71.11B??????????????????????????????????? ??????????????????????????????Headquarters: New Jersey- US

BD is a global medical technology company engaged in the development- manufacture- and sale of a broad range of medical supplies- devices- laboratory equipment and diagnostic products for physicians- life science researchers- clinical laboratories- the pharmaceutical industry- and the general public. In 2020- BD received CE Mark for its portable- rapid POC antigen test to detect SARS-CoV-2 in 15 minutes and got CE Mark for combination COVID-19- Influenza- RSV Test on BD MAX Molecular diagnostic system.

Diagnostic Revenue: $5.34B                                                          Total Employees: ~75-000

Founded Year: 1902                                                                         Stock Exchange: NYSE

Market Cap: ~$178.23B ?????????????????????????????????????????????????????????????????Headquarters: Massachusetts- US

Thermo Fisher is globally serving its primary brands: Thermo Scientific- Applied Biosystems- Invitrogen- Fisher Scientific- and Unity Lab Services. The company has four main segments: Life Sciences Solutions- Analytical Instruments- Specialty Diagnostics- and Laboratory Products and Services. The company develops Applied Biosystems TaqPath COVID-19 Combo Kit- which received EUA n in the US in Mar?2020- followed by similar authorizations around the world. The company significantly expanded the portfolio of COVID-19 related products- launching the Thermo Fisher Scientific Amplitude Solution for high-throughput PCR-based testing and our Applied Biosystems TaqCheck PCR test for asymptomatic health surveillance. These innovations allow the company to establish worldwide leadership in COVID-19 diagnostic testing- supporting millions of COVID-19 PCR tests across the world.

Diagnostic Revenue: $7.40B                                                       Total Employees: ~69-000

Founded Year: 1969                                                                      Stock Exchange: NYSE

Market Cap: ~$173.83B???????????????????????????????????????????????????????????????Headquarter: Washington- D.C- US?????

Danaher Corporation designs manufacture and markets professional- medical- industrial- and commercial products and services. The company has a focus on Life Sciences- Diagnostics- Dental- and Environmental & Applied Solutions. The Company?s diagnostics segment offers analytical instruments- reagents- consumables- software- and services. In Mar? 2020- the company completed the acquisition of GE LifeScience?s biopharma business knows as Cytiva.

Diagnostic Revenue: $9.25B                                                          Total Employees: ~80-000

Founded Year: 1971                                                                         Stock Exchange: NYSE

Market Cap:   ~$25.49B                                                                   Headquarter: North Carolina- US

LabCorp is a leading global life sciences company targeting in guiding patient care. In 2020- Labcorp received FDA?s authorization to make at-home COVID-19 collection kits available through retail and collaborated with GENFIT to commercialize novel diagnostic test for liver diseases. Moreover- the company collaborated with public health authorities on no-charge antibody test program to accelerate COVID-19 blood plasma donation.

Diagnostic Revenue: $10.00B                                                          Total Employees: ~81-592

Founded Year: 1891                              &nbs